With funding dwindling, how can biotech companies maintain momentum?
06 December, 2022 by Glenn Bilawsky, CEOPartnering with biopharmaceutical outsourcing companies provides an opportunity for drug and diagnostic developers to better leverage their assets.
Gene therapy trial for type 1 diabetes to proceed
30 November, 2022The trial is set to be the first time that genetically engineered pancreatic islet cells will be transplanted into humans to treat type 1 diabetes.
$352m plasma therapeutics plant coming to Qld
29 November, 2022Aegros, which is currently based in Sydney, will establish its global headquarters and a one-million-litre plasma fractionation facility in Springfield's BioPark Australia precinct.
A second chance for UQ's molecular clamp vaccine platform
28 November, 2022UQ is set to take a second-generation 'molecular clamp' vaccine to a proof-of-concept human trial, after CEPI announced funding to support the technology.
Syringe to improve sperm selection for infertile couples
25 November, 2022Bioengineering researchers have developed a syringe that uses a 3D filter to detect and isolate viable sperm in less than 15 minutes.
Urine could play a key part in biotech systems
22 November, 2022A common chemical found in urine can be used to kick-start large-scale production of proteins such as hormones and antibodies used by biotech companies.
Bionic pancreas simplifies type 1 diabetes management
14 November, 2022Compared to other available artificial pancreas technologies, the bionic pancreas is designed to require less user input and provides more automation.
Drug found to reduce sleep apnoea severity
09 November, 2022A drug previously used to treat depression has been found to reduce obstructive sleep apnoea severity.
DNA nanotransporters optimise drug delivery
09 November, 2022Researchers have designed a new class of drug transporters made of DNA that are 20,000 times smaller than a human hair and could improve how diseases are treated.
Breakthrough for drug delivery through blood–brain barrier
28 October, 2022In a major advance for the treatment of Alzheimer's, Australian scientists have successfully delivered drugs through patient cell models of the human blood–brain barrier.
Five-year project to develop next-gen TB vaccines
10 October, 2022The Centenary Institute and the University of Sydney have been awarded a $19m contract to develop the next generation of tuberculosis vaccines.
Brain cancer drug candidate fast-tracked in clinical trials
10 October, 2022An experimental drug for advanced solid tumours, including aggressive glioblastoma, has passed the first phase of clinical trials with flying colours.
TGA approves Pfizer vaccine in under-fives
30 September, 2022The TGA has provisionally approved Pfizer's COVID-19 vaccine for children aged six months and over, and as a booster dose in children five years and over.
Vaxxas to scale up its vaccine skin patch facility
28 September, 2022Biotech company Vaxxas will receive $8.2m from the Modern Manufacturing Initiative to support the scale-up of its potentially game-changing technology.
New ways to beat chronic pain
09 September, 2022A new study points to possible treatments for chronic pain with a surprising link to lung cancer.
